ABAC-40105

N/A

Report date: 2025/01/26 15:58:35
NME

Base Information

Drug NameABAC-40105
Drug Alias NameABAC-40105
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAcinetobacter Baumannii InfectionsMultidrug-Resistant InfectionKlebsiella Infections +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesABAC Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesABAC Therapeutics
Inactive CompaniesN/A
Active IndicationsAcinetobacter Baumannii InfectionsMultidrug-Resistant InfectionKlebsiella Infections +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A